Faculty Opinions recommendation of A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

2013 ◽  
Author(s):  
Carmine Pariante ◽  
Valeria Mondelli
Keyword(s):  
Tumor Necrosis ◽  
Controlled Trial ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Tumor Necrosis Factor Antagonist ◽  
Randomized Controlled ◽  
Resistant Depression ◽  
Factor Antagonist ◽  
Necrosis Factor

scholarly journals Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial

2019 ◽  
Vol 176 (5) ◽  
pp. 401-409 ◽  
Author(s):  
Jennifer L. Phillips ◽  
Sandhaya Norris ◽  
Jeanne Talbot ◽  
Meagan Birmingham ◽  
Taylor Hatchard ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Randomized Controlled ◽  
Resistant Depression
Sign in / Sign up

Export Citation Format

Share Document